Public Comment: DOAC and CAT VTE Treatment

Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: Updated guidance from the SSC of the ISTH: Open for Public Review

The ISTH has recently drafted an updated guidance manuscript on the role of DOAC in the treatment of cancer-associated VTE. The guidance was developed by a panel of 7 content experts.

The draft guidance is available for review HERE.

We now kindly ask the greater community of physicians, scientists, and allied health professionals to review and provide any comments by November 5, 2026.

Note: This manuscript is confidential and in draft form.

1. Please enter your information, due to conflict of interest concerns, anonymous comments will not be accepted.
Comments will not be attributed, published or provided to anyone beyond the Guideline and Guidance Committee.

First Name *This question is required.

Last Name *This question is required.

Title

Institution *This question is required.

Country *This question is required.

Email Address *This question is required. This question requires a valid email address.

2. Please indicate any financial or intellectual conflicts of interest you may have related to your comments on this guideline: *This question is required.

3. To which section does your comment apply? *This question is required.

Page, table or figure number:

Comment:

4. To which section does your comment apply? *This question is required.

Page, table or figure number:

Comment:

5. To which section does your comment apply? *This question is required.

Page, table or figure number:

Comment:

6. To which section does your comment apply? *This question is required.

Page, table or figure number:

Comment:

7. To which section does your comment apply? *This question is required.

Page, table or figure number:

Comment:

Click the submit button below to send your comments. If you would like to make additional comments, you may submit additional forms.